Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland.
JMIR Mhealth Uhealth. 2022 May 6;10(5):e33735. doi: 10.2196/33735.
Women's mobile health (mHealth) is a growing phenomenon in the mobile app global market. An increasing number of women worldwide use apps geared to female audiences (female technology). Given the often private and sensitive nature of the data collected by such apps, an ethical assessment from the perspective of data privacy, sharing, and security policies is warranted.
The purpose of this scoping review and content analysis was to assess the privacy policies, data sharing, and security policies of women's mHealth apps on the current international market (the App Store on the Apple operating system [iOS] and Google Play on the Android system).
We reviewed the 23 most popular women's mHealth apps on the market by focusing on publicly available apps on the App Store and Google Play. The 23 downloaded apps were assessed manually by 2 independent reviewers against a variety of user data privacy, data sharing, and security assessment criteria.
All 23 apps collected personal health-related data. All apps allowed behavioral tracking, and 61% (14/23) of the apps allowed location tracking. Of the 23 apps, only 16 (70%) displayed a privacy policy, 12 (52%) requested consent from users, and 1 (4%) had a pseudoconsent. In addition, 13% (3/23) of the apps collected data before obtaining consent. Most apps (20/23, 87%) shared user data with third parties, and data sharing information could not be obtained for the 13% (3/23) remaining apps. Of the 23 apps, only 13 (57%) provided users with information on data security.
Many of the most popular women's mHealth apps on the market have poor data privacy, sharing, and security standards. Although regulations exist, such as the European Union General Data Protection Regulation, current practices do not follow them. The failure of the assessed women's mHealth apps to meet basic data privacy, sharing, and security standards is not ethically or legally acceptable.
女性移动健康(mHealth)是移动应用全球市场中日益增长的现象。全球越来越多的女性使用针对女性受众的应用程序(女性技术)。鉴于此类应用程序收集的数据通常具有隐私性和敏感性,因此需要从数据隐私、共享和安全政策的角度进行伦理评估。
本研究的目的是评估当前国际市场(苹果操作系统上的 App Store 和安卓系统上的 Google Play)上女性移动健康应用程序的隐私政策、数据共享和安全政策。
我们通过专注于 App Store 和 Google Play 上公开可用的应用程序,对市场上 23 款最受欢迎的女性移动健康应用程序进行了审查。这 23 个下载的应用程序由 2 名独立审查员手动评估,评估标准包括各种用户数据隐私、数据共享和安全评估标准。
所有 23 个应用程序都收集了与个人健康相关的数据。所有应用程序都允许进行行为跟踪,并且有 61%(14/23)的应用程序允许进行位置跟踪。在这 23 个应用程序中,只有 16 个(70%)显示了隐私政策,12 个(52%)向用户请求了同意,1 个(4%)有伪同意。此外,在获得同意之前,有 13%(3/23)的应用程序收集了数据。大多数应用程序(20/23,87%)与第三方共享用户数据,而对于其余 13%(3/23)的应用程序,无法获取数据共享信息。在这 23 个应用程序中,只有 13 个(57%)向用户提供了数据安全信息。
市场上许多最受欢迎的女性移动健康应用程序的数据隐私、共享和安全标准较差。尽管存在法规,例如欧盟通用数据保护条例,但目前的做法并没有遵循这些法规。评估的女性移动健康应用程序未能满足基本的数据隐私、共享和安全标准,这在道德和法律上都是不可接受的。